SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Drug discovery is one of the most expensive failures in modern industry. Finding a single viable molecule can take a decade and cost billions, and most candidates still don’t make it. A generation of AI startups has promised to fix that — most have made the problem less painful for researchers who are already technically sophisticated enough to use the tools.
But SandboxAQ thinks the bottleneck isn’t the models. It’s the interface.
The company has teamed up with Anthropic to integrate its scientific AI models directly into Claude — putting powerful drug discovery and materials science tools behind a conversational interface that requires no specialized computing infrastructure to use.
Founded roughly five years ago as an Alphabet spinout, SandboxAQ counts Eric Schmidt, Google’s former CEO, as its chairman. The company, which has raised more than $950 million from investors, has built out a number of different business lines, including ...
Copyright of this story solely belongs to techcrunch.com. To see the full text click HERE
